Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Parslow, Ruth ^a,b   Purcell, Rosemary ^a   Garner, Belinda ^a   Hetrick, Sarah E ^a  

^a ORYGEN RESEARCH CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUTE STRESS DISORDER; ANXIETY; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; COMPARATIVE STUDY; DEPRESSION; DISEASE SEVERITY; DRUG TOLERABILITY; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PATIENT COUNSELING; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC TREATMENT; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PSYCHOTRAUMA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUICIDAL IDEATION; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

EID: 55049124706     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007316     Document Type: Review

References (26)

1. APA 1980 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington, DC: American Psychiatric Association, 1980.
2. APA 1994 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: American Psychiatric Association, 1994.
3. Ballenger 2000 Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Foa EB, Kessler RC, et al.Consensus Statement on Posttraumatic Stress Disorder from the International Consensus Group on Depression and Anxiety. Journal of Clinical Psychiatry 2000;61 Suppl 5:60-6.
4. Ballenger 2004 Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Marshall RD, Nemeroff CB, et al.Consensus Statement update on posttraumatic stress disorder from the International Consensus Group on Depression and Anxiety. Journal of Clinical Psychiatry 2004;65 Suppl 1:55-62.
5. Bisson 2005 Bisson J, Andrew M. Psychological treatment of posttraumatic stress disorder (PTSD).Cochrane Database of Systematic Reviews 2005, Issue 3.
6. Boehnlein 1985 Boehnlein JK, Kinzie JD, Ben R, Fleck J. One-year follow-up study of posttraumatic stress disorder among survivors of Cambodian concentration camps. American Journal of Psychiatry 1985;142:956- 9.
7. Davidson 1992 Davidson J. Drug therapy for post-traumatic stress disorder. British Journal of Psychiatry 1992;160:309-14.
8. Davidson 1999 Davidson JR, Connor KM. Management of posttraumatic stress disorder: Diagnostic and therapeutic issues. Journal of Clinical Psychiatry 1999;60 Suppl 18:33-8.
9. Davidson 2000 Davidson JR. Pharmacotherapy of posttraumatic stress disorder: Treatment options, long-term follow-up, and predictors of outcome. Journal of Clinical Psychiatry 2000;61 Suppl 5:52-6.
10. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
11. Elbourne 2002 Elbourne DR, Altman DG, Higgins JP, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology 2002;31(1):140-9.
12. Friedman 1988 Friedman MJ. Toward rational pharmacotherapy for posttraumatic stress disorder: An interim report. American Journal of Psychiatry 1988;145:281-285.
13. Hamner 2005 Hamner MB, Robert S. Emerging roles for atypical antipsychotics in chronic post-traumatic stress disorder. Expert Review of Neurotherapeutics 2005;5(2):267-75.
14. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60.
15. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [Updated February 2008]. The Cochrane Collaboration 2008. Available from www.cochranehandbook.org.
16. Juni 2001 Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. BMJ 2001;323:42-6.
17. Kessler 1995 Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the National Comorbidity Survey. Archives of General Psychiatry 1995;52(12):1048-60.
18. Lopez-Ibor 2002 Lopez-Ibor JJ. The classification of stress-related disorders in ICD-10 and DSM-IV. Psychopathology 2002;35(2/3):107-11.
19. Mantel 1959 Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the Nationall Cancer Institute 1959;22:719-48.
20. Marshall 2000 Marshall RD, Cloitre M. Maximizing treatment outcome in posttraumatic stress disorder by combining psychotherapy with pharmacotherapy. Current Psychiatry Reports 2000;2:335-40.
21. Mylle 2004 Mylle J, Maes M. Partial posttraumatic stress disorder revisited. Journal of Affective Disorders 2004;78:37-48.
22. Nemeroff 2006 Nemeroff CB, Bremmer JD, Foa EB, Mayberg HS, North CS, Stein MB. Posttraumatic stress disorder: A state-of-the-science review. Journal of Psychiatric Research 2006;40:1-21.
23. Olff 2007 Olff M, OLangeland W, Draijer N, Gersons BPR. Gender differences in posttraumatic stress disorder. Psychological Bulletin 2007;133(2): 183-204.
24. Peters 2006 Peters L, Issakidis C, Slade T, Andrews G. Gender differences in the prevalence of DSM-IV and ICD-10 PTSD and ICD-10 PTSD. Psychological Medicine 2006;36:81-9.
25. Stein 2006 Stein DJ, Ipser JC, Seedat S. Pharmacotherapy for posttraumatic stress disorder (PTSD). Cochrane Database of Systematic Reviews 2006, Issue 1.
26. Yehuda 1999 Yehuda R. Biological factors associated with susceptibility to posttraumatic stress disorder to posttraumatic stress disorder Biological factors associated with susceptibility to posttraumatic stress disorder. Canadian Journal of Psychiatry 1999;44(1):34-9.